David Bancroft Avrick is a successful entrepreneur and business leader with a diverse professional background. He started his career as an attorney, specializing in mergers & acquisitions, securities, and corporate law. After practicing law for several years, Avrick turned his attention to the business world, where he has made his mark as an accomplished executive and investor.

As a leader, Avrick has worked in a variety of industries, including tech, healthcare, and finance. He has held executive positions at several companies, including CEO of TouchPointCare, COO of Bionik Laboratories, and President of Entrex Capital Market. He has also served on the board of directors for numerous organizations, like Global Synergy Corporation and the Alzheimer's Association.

Avrick's expertise in raising capital, scaling businesses, and negotiating deals has been critical to his success. He has helped secure millions of dollars in funding for startups and established companies alike. He has also been involved in several high-profile mergers and acquisitions, including the sale of Generex Biotechnology to Oramed Pharmaceuticals and the acquisition of Pinnacle Care International by Touchstone Health.

Despite his busy schedule, Avrick is also committed to giving back to his community. He serves as a board member for multiple non-profit organizations, including the National Psoriasis Foundation and the Temple Beth El Foundation.

David Bancroft Avrick is a skilled business leader, investor, and philanthropist who has made a significant impact in various fields. His extensive knowledge and experience in law, finance, and entrepreneurship have helped numerous companies achieve success.